Brief: Salarius Pharmaceuticals Reports Business Highlights With Fourth Quarter And Full-Year 2021 Financial Results

Decoy Therapeutics

10/03/2022 21:18

March 10 (Reuters) - Salarius Pharmaceuticals Inc  SLRX.O :
    * SALARIUS PHARMACEUTICALS REPORTS BUSINESS HIGHLIGHTS WITH
FOURTH
QUARTER AND FULL-YEAR 2021 FINANCIAL RESULTS
    * CASH AND CASH EQUIVALENTS TOTAL $29.2 MILLION ON DECEMBER
31,
2021, WITH AN ESTIMATED RUNWAY INTO 2023
    * QTRLY LOSS PER SHARE $0.09
    * Q4 EARNINGS PER SHARE VIEW $-0.09 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX5F94Lb 
Further company coverage:  SLRX.O